US 9737520
Aclidinium for use in improving the quality of sleep in respiratory patients
granted A61KA61K31/439A61K45/06
Quick answer
US patent 9737520 (Aclidinium for use in improving the quality of sleep in respiratory patients) held by Almirall, S.A. expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/439, A61K45/06, A61K9/0073, A61K9/0075